Recombinant Human APAF1 Protein (Yeast)，His

APAF1 (apoptosis protease activating factor 1) is a critical component of the apoptosome, a multi-protein complex that plays a pivotal role in the intrinsic pathway of apoptosis. The activation of APAF1 is mediated by cytochrome c released from mitochondria, which then binds to APAF1, leading to its conformational change and oligomerization into a heptameric structure. This process facilitates the recruitment and activation of procaspase-9, ultimately triggering a cascade of caspase activation that results in programmed cell death. Given its central role in apoptosis, dysregulation of APAF1 is implicated in various pathological conditions, including cancer, neurodegenerative diseases, and autoimmune disorders, where evasion of apoptosis contributes to disease progression. Research on recombinant APAF1 protein has gained momentum as it presents a valuable tool for understanding the molecular mechanisms governing apoptosis and for developing potential therapeutic strategies. By producing and characterizing recombinant APAF1, researchers aim to elucidate its structure-function relationships, investigate its interactions with other apoptotic proteins, and explore its regulatory mechanisms. Furthermore, studying APAF1 in vitro and in vivo could lead to novel insights into how target molecules can modulate its activity, potentially paving the way for innovative treatments that restore apoptotic processes in disease contexts. Overall, recombinant APAF1 serves not only as a model for studying apoptosis but also as a potential therapeutic target in cancer and other diseases characterized by dysregulated cell death.